作者:
Avet-Loiseau,H. [1]
;
Durie,B.G.M. [2]
;
Cavo,M. [3]
;
Attal,M. [4]
;
Gutierrez,N. [5]
;
Haessler,J. [6]
;
Goldschmidt,H. [7]
;
Hajek,R. [8]
;
Lee,J.H. [9]
;
Sezer,O. [10]
;
Barlogie,B. [11]
;
Crowley,J. [12]
;
Fonseca,R. [13]
;
Testoni,N. [14]
;
Ross,F. [15]
;
Rajkumar,S.V. [16]
;
Sonneveld,P. [17]
;
Lahuerta,J. [18]
;
Moreau,P. [19]
;
Morgan,G.
作者单位:
Hematology Department, University Hospital, Toulouse, France
[1]
Hematology Department, UniversitatKlinikum Charite, Berlin, Germany
[2]
Southwest Cooperative Oncology Group, MIRT UAMS, Little Rock, AR, United States
[3]
Hematology Department, University Hospital Heidelberg, Heidelberg, Germany
[4]
LLR UKMF Cytogenetic Database, University of Southampton, Salisbury, United Kingdom
[5]
Cytogenetic Laboratory, University of Salamanca, Salamanca, Spain
[6]
Cancer Research and Biostatistics, Seattle, WA, United States
[7]
Eastern Cooperative Oncology Group (ECOG), Mayo Clinic, Rochester, MN, United States
[8]
Southwest Cooperative Oncology Group, Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA
[9]
Universita di Bologna, Bologna, Italy
[10]
Hematology Department, Gachon University Gil Hospital, Incheon, South Korea
[11]
Royal Marsden Hospital, London, United Kingdom
[12]
Mayo Clinic Arizona, Scottsdale, AZ, United States
[13]
Hematology Department, Brno University, Brno, Czech Republic
[14]
Hematology Department, University Hospital, Center for Research in Myeloma, Nantes, France
[15]
Unité de Génomique du Myélome, Laboratoire UGM, University Hospital, 31059 Toulouse Cedex 9, France
[16]
Laboratory of Cytogenetics, Seràgnoli Institute of Hematology, Bologna University School of
[17]
Erasmus MC, Rotterdam, Netherlands
[18]
Grupo Espa? Ol di Mieloma, Hospital Universitario, Madrid, Spain
[19]
发布时间
2013-11-20